Media coverage about Henry Schein (NASDAQ:HSIC) has been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Henry Schein earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave news articles about the company an impact score of 48.6203342716964 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Here are some of the news articles that may have effected Accern’s rankings:

A number of equities analysts have recently commented on HSIC shares. Credit Suisse Group reaffirmed a “hold” rating and issued a $160.00 price target on shares of Henry Schein in a report on Thursday, July 13th. Stifel Nicolaus raised their price target on Henry Schein from $174.00 to $178.00 and gave the stock a “hold” rating in a report on Wednesday, May 10th. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $204.00 price target for the company in a report on Thursday, May 25th. Piper Jaffray Companies started coverage on Henry Schein in a report on Monday, June 12th. They issued a “neutral” rating and a $200.00 price target for the company. Finally, BidaskClub lowered Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, August 2nd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and seven have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $185.56.

Henry Schein (NASDAQ HSIC) traded down 1.37% during midday trading on Thursday, reaching $167.32. The company had a trading volume of 631,913 shares. Henry Schein has a 52 week low of $146.23 and a 52 week high of $186.99. The company has a market capitalization of $13.25 billion, a price-to-earnings ratio of 24.45 and a beta of 1.09. The firm has a 50-day moving average price of $181.94 and a 200-day moving average price of $175.01.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, topping the consensus estimate of $1.73 by $0.02. The firm had revenue of $3.06 billion during the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. Henry Schein’s revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.64 EPS. Analysts expect that Henry Schein will post $7.28 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Henry Schein (HSIC) Earns Daily News Sentiment Rating of 0.11” was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.dailypolitical.com/2017/08/10/henry-schein-hsic-earns-daily-news-sentiment-rating-of-0-11.html.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Insider Buying and Selling by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.